Evidence map›Paper›PMID 22515871›Full record

Trial reportAmerican journal of public health2012

Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial.

Lisa R Metsch, Daniel J Feaster, Lauren Gooden, Tim Matheson, Raul N Mandler, Louise Haynes, Susan Tross, Tiffany Kyle, Dianne Gallup, Andrzej S Kosinski and 12 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in American journal of public health, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00809445 (HIV Rapid Testing and Counseling in Drug Abuse Treatment Programs in the U.S.), which is not on this map. Cited by 80 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 8 pooled it
6.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00809445 phase3completednot on this map

HIV Rapid Testing and Counseling in Drug Abuse Treatment Programs in the U.S.

TypeinterventionalSponsorUniversity of MiamiRan2009 to 2010Enrolled1,281ConditionsSubstance-Related DisordersArmsOn-site HIV rapid test and brief, prevention counseling, On- site HIV rapid test & information, Referral for off-site HIV testing
3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 8 syntheses or guidelines pooled it, 102 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Guideline
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 1 institution in 1 country.

Lisa R MetschDepartment of Epidemiology and Public Health, University of Miami Miller School of Medicine, Miami, FL 33136, USA. Lmetsch@med.miami.edu
Daniel J Feaster
Lauren Gooden
Tim Matheson
Raul N Mandler
Louise Haynes
Susan Tross
Tiffany Kyle
Dianne Gallup
Andrzej S Kosinski
Antoine Douaihy
Bruce R Schackman
Moupali Das
Robert Lindblad
Sarah Erickson
P Todd Korthuis
Steve Martino
James L Sorensen
José Szapocznik
Rochelle Walensky
Bernard Branson
Grant N Colfax
Alkermes (Ireland) · IE

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI Daniel Lingwood · 2004 to 2026
$94.4M
FLORIDA NODE OF THE DRUG ABUSE CLINICAL TRIALS NETWORKU10DA013720 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI METSCH, LISA R, SZAPOCZNIK, JOSE · 2000 to 2015
$56.9M
The Statistics, Data Science, and Data Management (SDM) CoreP30MH043520 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI Claude Ann Mellins · 2003 to 2026
$48.2M
Clinical Trials Network, Ohio Valley Node U10DA013732U10DA013732 · NIDA · UNIVERSITY OF CINCINNATI · PI WINHUSEN, T JOHN · 2000 to 2015
$45.0M
Southern Consortium Node of the Clinical Trials NetworkU10DA013727 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2000 to 2015
$34.4M
Western States Node of the National Drug Abuse Treatment Clinical Trials NetworkU10DA015815 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MCCARTY, DENNIS, SORENSEN, JAMES L · 2002 to 2015
$25.2M
CLINICAL TRIALS NETWORK MID-ATLANTIC COLLABORATIVE GROUPU10DA013034 · NIDA · JOHNS HOPKINS UNIVERSITY · PI SCHWARTZ, ROBERT P, STITZER, MAXINE L · 1999 to 2015
$25.2M
Western States Node of the National Drug Abuse Treatment Clinical Trials Network (TMS for CUD) UG1DA015815 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Keith N. Humphreys, Philip Todd Korthuis · 2015 to 2026
$24.6M
Clinical Trials Network: Southwest NodeU10DA015833 · NIDA · UNIVERSITY OF NEW MEXICO · PI MCCRADY, BARBARA S · 2002 to 2014
$19.9M
OREGON NODE - NATIONAL CLINICAL TRIALS NETWORKU10DA013036 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI MCCARTY, DENNIS · 1999 to 2010
$18.5M
CLINICAL TRIALS NETWORK: NEW ENGLAND NODEU10DA013038 · NIDA · YALE UNIVERSITY · PI CARROLL, KATHLEEN M. · 1999 to 2010
$17.3M
CLINICAL TRIAL RESEARCH PROJECT COREU10DA020036 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DALEY, DENNIS C · 2005 to 2015
$14.1M
NIAID NIH HHS P30 AI060354NIDA NIH HHS HHSN271200522071CNIDA NIH HHS K23 DA019809NIDA NIH HHS U10 DA013034NIDA NIH HHS U10 DA013036NIDA NIH HHS U10 DA013038NIDA NIH HHS U10DA013038NIDA NIH HHS U10 DA013720NIDA NIH HHS U10DA013720NIDA NIH HHS U10 DA013727NIDA NIH HHS U10 DA013732NIDA NIH HHS U10DA013732NIDA NIH HHS U10 DA015815NIDA NIH HHS U10 DA015833NIDA NIH HHS U10DA015833NIDA NIH HHS U10 DA020036NIDA NIH HHS U10DA020036NIDA NIH HHS U10DA13034NIDA NIH HHS U10DA13036NIDA NIH HHS U10DA13720-09SNIDA NIH HHS U10DA13727NIDA NIH HHS U10DA15815NIDA NIH HHS UG1 DA015815NIMH NIH HHS P30 MH043520PHS HHS HHSN271200522081C
6 · The paper itself

Abstract

objectivesWe examined the effectiveness of risk reduction counseling and the role of on-site HIV testing in drug treatment.

methodsBetween January and May 2009, we randomized 1281 HIV-negative (or status unknown) adults who reported no past-year HIV testing to (1) referral for off-site HIV testing, (2) HIV risk-reduction counseling with on-site rapid HIV testing, or (3) verbal information about testing only with on-site rapid HIV testing.

resultsWe defined 2 primary self-reported outcomes a priori: receipt of HIV test results and unprotected anal or vaginal intercourse episodes at 6-month follow-up. The combined on-site rapid testing participants received more HIV test results than off-site testing referral participants (P<.001; Mantel-Haenszel risk ratio=4.52; 97.5% confidence interval [CI]=3.57, 5.72). At 6 months, there were no significant differences in unprotected intercourse episodes between the combined on-site testing arms and the referral arm (P=.39; incidence rate ratio [IRR]=1.04; 97.5% CI=0.95, 1.14) or the 2 on-site testing arms (P=.81; IRR=1.03; 97.5% CI=0.84, 1.26).

conclusionsThis study demonstrated on-site rapid HIV testing's value in drug treatment centers and found no additional benefit from HIV sexual risk-reduction counseling.

Indexed as

HIVAdultCounselingFemaleFollow-Up StudiesHIV InfectionsHumansMaleMass ScreeningMiddle AgedProgram EvaluationRisk Reduction BehaviorSubstance Abuse Treatment CentersUnited StatesUnsafe Sex

Identifiers

PMID22515871
PMCPMC3483949
OpenAlexW2042637887

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.